Executive VP, Bus. Unit Lead of Consumer Healthcare and General Counsel
Ms. Amy W. Schulman is Executive Vice President, General Counsel, Business Unit Lead Consumer Healthcare of Pfizer Inc. She was Executive Vice President and General Counsel since December 2010 and Business Unit Lead, Consumer Healthcare for Pfizer since August 2012. Executive Vice President and General Counsel; President and General Manager, Nutrition from December 2010 until November 2012. Senior Vice President and General Counsel from June 2008 until December 2010. Ms. Schulman was a partner at the law firm of DLA Piper from 1997 until joining Pfizer in June 2008. Currently a Director of Zoetis and Chair of the Zoetis Corporationrationrate Governance Committee, Member of the Board of Directors of Wesleyan University and the Brooklyn Academy of Music.
The company has Return on Asset of 6.22 % which means that on every $100 spent on asset it made $6.22 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 12.68 % implying that it generated $12.68 on every 100 dollars invested.
The company has 40.4 B in debt with debt to equity (D/E) ratio of 0.49 which is OK given its current industry classification. Pfizer Inc has Current Ratio of 2.3 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Pfizer Inc [PFE] is traded on New York Stock Exchange in USA. It is located in New York, NY and employs 89,400 people. Filter other
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
NYSE Pfizer Inc
-0.06% 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Advice
Buenos-Aires
Mexico
Munich
Brussels
London
Stockholm
